Focused Wealth Management’s Gilead Sciences GILD Stock Holding History

Focused Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8,000	Closed	-$19K	–	969
2021 Q1	$19K	Buy	+8,000	New	+$516K	﹤0.01%	508
2018 Q2	–	Sell	-11,000	Closed	-$7K	–	692
2018 Q1	$7K	Buy	+11,000	New	+$874K	﹤0.01%	519
2017 Q4	–	Sell	-10,000	Closed	-$5K	–	707
2017 Q3	$5K	Buy	+10,000	New	+$765K	﹤0.01%	512
2015 Q4	–	Hold	0	–	-$767K	–	689
2015 Q3	–	Hold	0	–	–	–	40

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Focused Wealth Management's GILD Position: Q2 2026 in Review

Focused Wealth Management opened a new position in Gilead Sciences (GILD) in Q2 2026: 1,784 shares worth $225K. The stake represents 0.02% of the portfolio and ranks #221 among its holdings. This is a return to the name: Focused Wealth Management previously reported a position in GILD as recently as Q4 2023.

Focused Wealth Management first reported a position in GILD in Q2 2014 and has held it in 40 quarters since. The position peaked at $2.02M in Q3 2017. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Focused Wealth Management held 1,784 shares of Gilead Sciences worth $225K as of Q2 2026.
Gilead Sciences was a new Focused Wealth Management position in Q2 2026.
Gilead Sciences made up 0.02% of Focused Wealth Management's portfolio in Q2 2026, its #221 holding.
Focused Wealth Management first reported a position in Gilead Sciences in Q2 2014 and has held it in 40 quarters since.
Focused Wealth Management's Gilead Sciences position peaked at $2.02M in Q3 2017.
2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Focused Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.